Patents-Review.com
ClassID:

170908 ⎘

G01N2800/7047 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Mechanisms involved in disease identification Fibrils-Filaments-Plaque formation

Recent Application in this class:
#1
20260049305
2026-02-19

CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION

 #2
20250154235
2025-05-15

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

 #3
20250145699
2025-05-08

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

 #4
20250129363
2025-04-24

CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION

 #5
20250084157
2025-03-13

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

 #6
20250060375
2025-02-20

ALPHA-SYNUCLEIN DETECTION ASSAY

 #7
20250027957
2025-01-23

ALPHA-SYNUCLEIN DETECTION ASSAY AND METHOD FOR DIAGNOSING ALPHA-SYNUCLEINOPATHIES

 #8
20240183864
2024-06-06

Compositions and methods for detecting proteinopathies

 #9
20240084293
2024-03-14

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation

 #10
20230366893
2023-11-16

METHODS TO DETERMINE RISK OF NEUROTOXICITY

 #11
20230032690
2023-02-02

NEW TAU SPECIES

 #12
20220144928
2022-05-12

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

 #13
20210405069
2021-12-30

Alpha-synuclein detection assay and method for diagnosing alpha- synucleinopathies

 #14
20210355202
2021-11-18

Antibody binding active α-synuclein

 #15
20210324060
2021-10-21

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

 #16
20210263049
2021-08-26

Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies

 #17
20210261634
2021-08-26

Light-inducible protein aggregation system for modeling proteinopathies and neurodegenerative disorders

 #18
20210195875
2021-07-01

NON-HUMAN ANIMALS EXHIBITING DEGENERATIVE SYMPTOM ATTRIBUTED TO PROTEIN AGGREGATION

 #19
20210179696
2021-06-17

Anti-PHF-tau antibodies and uses thereof

 #20
20210139569
2021-05-13

Antibody binding active alpha-synuclein

 #21
20210009666
2021-01-14

Humanized tau antibodies in Alzheimer's disease

 #22
20200369752
2020-11-26

Monoclonal antibodies against pathological alpha-synuclein, and methods using same

 #23
20200299682
2020-09-24

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation

 #24
20200299367
2020-09-24

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

 #25
20200277361
2020-09-03

Anti-transthyretin antibodies

 #26
20200181250
2020-06-11

Anti-transthyretin human antibody

 #27
20200031914
2020-01-30

ANTIBODIES RECOGNIZING MEDIN

 #28
20200031891
2020-01-30

NEW TAU SPECIES

 #29
20200010507
2020-01-09

Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments

 #30
20190345237
2019-11-14

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

 #31
20190302128
2019-10-03

Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies

 #32
20190263817
2019-08-29

Compounds for imaging Tau protein aggregates

 #33
20190195896
2019-06-27

Antibodies to TTR and methods of use

 #34
20190169276
2019-06-06

Humanized tau antibodies in alzheimer's disease

 #35
20190041390
2019-02-07

Identifying amyloidogenic proteins and amyloidogenic risk

 #36
20180298086
2018-10-18

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

 #37
20180267057
2018-09-20

Identification of immunoglobulin free light chains by mass spectrometry

 #38
20180265575
2018-09-20

Anti-PHF-tau antibodies and uses thereof

 #39
20180209994
2018-07-26

Method for treatment of traumatic brain injury targeting aggregated peptides

 #40
20180188270
2018-07-05

DIAGNOSTIC TEST FOR ALZHEIMER'S DISEASE BASED ON IDENTIFICATION OF A PROTEOLYTIC PATHWAY

 #41
20180142007
2018-05-24

Humanized tau antibodies in a alzheimer's disease

 #42
20180120334
2018-05-03

Compositions and methods for detecting proteinopathies

 #43
20170307638
2017-10-26

Detection of aggregated proteins associated with neurodegenerative disease using a photooxidation-induced amplification immunoassay

 #44
20170210791
2017-07-27

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

 #45
20170205431
2017-07-20

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

 #46
20170168065
2017-06-15

METHODS AND COMPOSITIONS FOR IMAGING VIA MOLECULAR BIASING

 #47
20170157274
2017-06-08

Compounds binding to neuropathological aggregates

 #48
20170121397
2017-05-04

Antibodies recognizing medin

 #49
20170115311
2017-04-27

Bacteriophage gene 3 protein compositions and use as amyloid binding agents

 #50
20170089929
2017-03-30

Antibodies to TTR and Methods of Use

 #51
20170088534
2017-03-30

3,6-disubstituted xanthylium salts

 #52
20170015737
2017-01-19

Anti-transthyretin antibodies

 #53
20160355576
2016-12-08

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

 #54
20160347832
2016-12-01

Anti-transthyretin humanized antibody

 #55
20160340419
2016-11-24

Anti-transthyretin human antibody

 #56
20160208235
2016-07-21

Detection and removal of misfolded proteins/peptides

 #57
20160178646
2016-06-23

METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS

 #58
20150140672
2015-05-21

METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS

 #59
20140044796
2014-02-13

Detection and removal of misfolded proteins/peptides

 #60
20130344079
2013-12-26

Compositions and methods for diagnosing and treating phenylketonuria (PKU)

 #61
20110300074
2011-12-08

3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies